3i Group PLC
Closed
SectorIndices
2,270
Overview
Share price change
24h
Min
2226
Max
2303
Income | -1.3B 2B |
|---|---|
Sales | 44M 236M |
P/E Sector Avg | 4.223 22.185 |
EPS | 3.4 |
Dividend yield | 3.74 |
Profit margin | 850.424 |
Employees | 223 |
EBITDA | -745M 2B |
Recommendations | Buy |
|---|---|
12 Months Forecast | +37.46% upside |
Dividend yield Sector Avg | 3.74% 3.18% |
|---|
Market Cap | -1.9B 23B |
|---|---|
Previous open | 2270 |
Previous close | 2270 |
News Sentiment
By Acuity
41%
59%
15 / 26 Indices
3i Group PLC Chart
Past performance is not a reliable indicator of future results.
About 3i Group PLC
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl